You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

194 Results
Document
Jan 2019
Guidelines and Advice
Status: Current
ID: N/A
Version: Final
May 2018
Document
Mar 2019
Document
May 2019
Document
May 2019
Guidelines and Advice
Status: In-Review
ID: GL 2-24
May 2019
Document
Jul 2019
Document
Jul 2019
Document
Sep 2019
Document
Sep 2019
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell, 
Rare Diseases
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
gemcitabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2019
Blog post
Dr. Leta Forbes, Medical OncologistProvincial Head, Systemic Treatment ProgramOntario Health (Cancer Care Ontario) Reactions to the injection of...
Sep 2019

Pages